Douglas Faller's most recent trade in Imunon Inc was a trade of 1,249 shares done at an average price of $1.1 . Disclosure was reported to the exchange on Oct. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.08 per share. | 09 Oct 2026 | 1,249 | 46,927 (0%) | 0% | 1.1 | 1,349 | - |
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.41 per share. | 25 Sep 2026 | 4,390 | 45,678 (0%) | 0% | 1.4 | 6,190 | - |
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.47 per share. | 11 Sep 2026 | 4,211 | 41,288 (0%) | 0% | 1.5 | 6,190 | Common Stock |
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.60 per share. | 28 Aug 2026 | 3,626 | 37,077 (0%) | 0% | 1.6 | 5,802 | Common Stock |
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.65 per share. | 14 Aug 2026 | 3,516 | 33,451 (0%) | 0% | 1.6 | 5,801 | Common Stock |
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.59 per share. | 31 Jul 2026 | 3,649 | 29,935 (0%) | 0% | 1.6 | 5,802 | Common Stock |
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.83 per share. | 17 Jul 2026 | 3,082 | 26,286 (0%) | 0% | 1.8 | 5,640 | Common Stock |
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.91 per share. | 02 Jul 2026 | 1,308 | 23,204 (0%) | 0% | 1.9 | 2,498 | Common Stock |
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 1.72 per share. | 25 Jun 2026 | 21,896 | 21,896 (0%) | 0% | 1.7 | 37,661 | Common Stock |
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | 02 Jan 2026 | 12,667 | 12,667 | - | - | Stock Option (Right to Buy) | ||
| Imunon Inc | Dr. Douglas Faller, M.D. | Chief Medical Officer | 18 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |